Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPB-01 in SJS/TEN unresponsive to corticosteroids
NCT01696500Phase 3Completed
- Sponsor
- Nihon Pharmaceutical
- Start
- Oct 2012
- Primary completion
- Jun 2014
- Modality
- Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of NPB-01-ME in Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), sponsored by Nihon Pharmaceutical. Started Oct 2012; status: completed.
02
Drugs
NPB-01-ME
03
Conditions
Stevens-Johnson syndrome (SJS)toxic epidermal necrolysis (TEN)
Beyond the preview
Go deeper on NCT01696500.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01696500.